Thomas J. Farrell
Keine laufenden Positionen mehr
Profil
Thomas J.
Farrell is the founder of Cylene Pharmaceuticals, Inc. (founded in 1997) and Artiva Biotherapeutics, Inc. (founded in 2019).
At Cylene Pharmaceuticals, he held the title of President & Chief Executive Officer.
At Artiva Biotherapeutics, he held the title of Chief Strategy Officer from 2019 to 2021.
Mr. Farrell's former jobs include being the President, Chief Executive Officer & Director at Bellicum Pharmaceuticals, Inc. from 2006 to 2017, and an Engineer at Cameron International Corp.
Mr. Farrell received his undergraduate degree from the University of Cambridge in 1984 and his MBA from Stanford Graduate School of Business.
Ehemalige bekannte Positionen von Thomas J. Farrell
| Unternehmen | Position | Ende |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Gründer | 01.10.2021 |
| BELLICUM PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 31.01.2017 |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Vorstandsvorsitzender | - |
| CAMERON INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Thomas J. Farrell
| University of Cambridge | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Cameron International Corp.
 Cameron International Corp. Oilfield Services/EquipmentIndustrial Services Cameron International Corp. designs, manufactures, markets and services equipment used by the oil and gas industry and industrial manufacturing companies. It provides flow equipment products, systems and services to worldwide oil, gas and process industries. The company was founded by Harry Cameron and James Abercrombie in 1920 and is headquartered in Houston, TX. | Industrial Services |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
